Showing results (1-10 of 331) with videos related to
Sort By:
Pageof 34
Blood|March 20, 2016
Is watch and wait still acceptable for patients with low-grade follicular lymphoma?James O Armitage, Dan L LongoJAMA Oncology|February 6, 2025
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative ReviewMark Roschewski, Dan L Longo, James O ArmitageBlood Advances|February 26, 2026
Persistence of PET Scan Positivity After Chemoimmunotherapy For DLBCLJames O Armitage, Matthew A Lunning, Julie M Vose, et al.American Journal of Hematology|April 18, 2012
The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and managementJames O ArmitageAmerican Journal of Hematology|June 3, 2015
The aggressive peripheral T-cell lymphomas: 2015James O ArmitageCurrent Hematologic Malignancy Reports|June 15, 2011
The importance of testing PET-directed therapy in patients with Hodgkin lymphomaJames O ArmitageTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 25, 2013
Clinically important variants of diffuse large B-cell lymphomaJames O ArmitageTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 16, 2013
Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?James O ArmitageOncology (Williston Park, N.Y.)|May 23, 2002
The role of mitoxantrone in non-Hodgkin's lymphomaJames O ArmitageAmerican Journal of Hematology|May 19, 2017
The aggressive peripheral T-cell lymphomas: 2017James O ArmitagePageof 34